首页
外语
计算机
考研
公务员
职业资格
财经
工程
司法
医学
专升本
自考
实用职业技能
登录
医学
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolu
admin
2013-11-30
26
问题
Without fanfare or legislation, the government is orchestrating a quiet revolution in how it regulates new medicines. The revolution is based on the idea that the sicker people are, the more freedom they should have to try drugs that are not yet fully tested. For fifty years government policy has been driven by another idea; the fear that insufficiently tested medicines could cause deaths and injuries. The urgent needs of people infected with HIV, the AIDS virus, and the possibility of meeting them with new drugs have created a compelling countervailing force to the continuing concern with safety. As a result, government rules and practices have begun to change. Each step is controversial. But the shift has already gone far beyond AIDS. New ways are emerging for very sick people to try some experimental drugs before they are marketed. People with the most serious forms of heart disease, cancer, emphysema, Alzheimer’ s or Parkinson’ s disease, multiple sclerosis, epilepsy , diabetes, or other grave illnesses can request such drugs through their doctors and are likelier to get them than they would have been four years ago. " We’ ve been too rigid in not making life-saving drugs available to people who otherwise face certain death," says Representative Henry Wax-man, of California, who heads the subcommittee that considers changes in drug-approval policies. "It’ s true of AIDS, but it’ s also true of cancer and other life-threatening diseases. "
For the first time, desperate patients have become a potent political force for making new medicines available quickly. People with AIDS and their advocates, younger and angrier than most heart-disease or cancer patients, are drawing on two decades of gay activists’ success in organizing to get what they want from politicians. At times they found themselves allied with Reagan Administration deregulators, scientists, industry representatives, FDA staff members, and sympathetic members of Congress. They organized their own clinical trials and searched out promising drugs here and abroad. The result is a familiar Washington story; a crisis—AIDS—helped crystallize an informal coalition for reform.
AIDS gave new power to old complaints. As early as the 1970s the drug industry and some independent authorities worried that the Food and Drug Administration’ s testing requirements were so demanding that new drugs were being unreasonably delayed. Beginning in 1972, several studies indicated that the United States had lost its lead in marketing new medicines and that breakthrough drugs, those that show new promise in treating serious or life—threatening diseases—had come to be available much sooner in other countries. Two high-level commissions urged the early release of breakthrough drugs. So did the Carter Administration, but the legislation it proposed died in Congress. Complaints were compounded by growing concern that "if we didn’ t streamline policies, red tape would be an obstacle to the development of the biotechnology revolution," as Frank E. Young, who was the head of the FDA from 1984 to 1989, put it in an interview with me.
Young was a key figure in the overhaul of the FDA’ s policies. A pioneer in biotechnology and a former dean of the University of Rochester’ s medical school, he came to Washington with an agenda and headed the agency for five and a half years—longer than anyone else has since the 1960s. Young took the FDA job to help introduce new medicines created by biotechnology—whose promise he had seen in his own gene-cloning lab and to get experimental medicines to desperately ill people more quickly. He had seen people die waiting for new medicines because " they were in the wrong place at the wrong time," he said. That is now changing.
It can be said that the people who first started the quiet drug revolution are______.
选项
A、doctors
B、government officials
C、AIDS patients
D、pharmacologists
答案
C
解析
第一段指出The revolution is based on the idea that the sicker people are…try drugs thatare not yet fully tested,表明对那些严重的病人来说,一种新药就是一线生机,因此他们才是这场药品变革的倡导者,选项C正确。
转载请注明原文地址:https://kaotiyun.com/show/rtU3777K
本试题收录于:
医学博士外语题库考研分类
0
医学博士外语
考研
相关试题推荐
下面哪一项是干扰素治疗的禁忌证
Cultureshockmightbecalledanoccupationaldiseaseofpeoplewhohavebeensuddenlytransplantedabroad.Likemostailments,
Cultureshockmightbecalledanoccupationaldiseaseofpeoplewhohavebeensuddenlytransplantedabroad.Likemostailments,
A、Becausetheydreadthattheywillhavetoseeapsychiatrist.B、Becausetheythinkthatanxietyanddepressionarenaturalres
A、Theresultsmightbereadytomorrowafternoon.B、Theresultsmightbereadytomorrowmorning.C、Theresultswillbereadythis
Therecentdeteriorationintheeconomyisofgreatconcerntothegovernment.
TheAmericanresearchuniversityisaremarkableinstitution,longasourceofadmirationandwonder.Theidyllic(田园诗的),wooded
FamedsingerSteveWondercan’tseehisfansdancingathisconcerts.Hecan’tseethehandsofhisaudienceastheyapplaudw
Usefuldrugsaremadefrominorganicsubstancesorareplantandanimalby-products.
随机试题
我国改革的总目的是( )。
宫内置环出现月经量增加,行经时间延长属于肝郁血瘀证者治法为
地龙具有的功效是()
五里湖大沟属淮海省凤山市,万庄站位于五里湖大沟右堤上,装机流量16.5m3/s,堤防级别为4级,配3台轴流泵,总装机3×355kW=1065kW。在工程建设过程中发生如下事件: 事件1:招标文件设定投标最高限价为3000万元。招标文件中有关投标
常用水泥的技术要求主要包括()。
在中文Word的“字体”对话框中,可以设定文字的()。
发行人申请在科创板上市的,证监会同意注册的决定自做出之日6个月内有效,发行人应当在注册决定有效期内发行股票,发行时点由发行人自主选择。()
揭示公共部门的管理人员具有“相互制造工作”特性,从而导致管理机构不断自我膨胀规律的法则是()
简述特别自首的概念及成立条件。
假定在窗体上添加了一个通用对话框控件,其名称为CD1,并有如下程序段:CD1.ShowOpen:CD1.DefaultExt="doc"在打开文件的对话框中选择了"c:\filel.txt"文件,则FileTitle属性的值是
最新回复
(
0
)